Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Epidemiology and Infection|May 17, 2000
Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from ChinaL Hou, D Osei-Hyiaman, Z Zhang, et al.
PPAR Research|March 20, 2010
PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver DiseaseJames P Hardwick, Douglas Osei-Hyiaman, Homer Wiland, et al.
Neurology|February 27, 2001
Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patientsL Hou, D Osei-Hyiaman, H Yu, et al.
Kango Kenkyu. the Japanese Journal of Nursing Research|March 1, 1997
[A study of the path diagram of the relationship between life style, mental health and psychosocial factors of nurses working at hospitals in Japan]M Suzuki, T Kashiwagi, M Oka, et al.
Diabetes|August 28, 2001
Association of a novel point mutation (C159G) of the CTLA4 gene with type 1 diabetes in West Africans but not in ChineseD Osei-Hyiaman, L Hou, R Zhiyin, et al.
Plos Neglected Tropical Diseases|December 14, 2020
Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged childrenDerick N M Osakunor, Takafira Mduluza, Douglas Osei-Hyiaman, et al.
Journal of Leukocyte Biology|July 27, 2007
Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosisMohanraj Rajesh, Hao Pan, Partha Mukhopadhyay, et al.
Pharmacology & Therapeutics|May 4, 2005
Evidence for novel cannabinoid receptorsMalcolm Begg, Pál Pacher, Sándor Bátkai, et al.
Annals of Surgery|April 29, 2008
Sustained weight loss after Roux-en-Y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial functionAna Guijarro, Douglas Osei-Hyiaman, Judith Harvey-White, et al.
Cell & Bioscience|June 12, 2015
Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequencesOgyi Park, Sung Hwan Ki, Mingjiang Xu, et al.
Pageof 4